in this issue
EnviroTech :: Biotech
Chemical Industry Weekly Innovation Round-Up, October 27
2:42 PM MDT | October 27, 2010 | Vincent Valk
Elevance and Stepan have signed a joint development agreement to look into and, eventually, commercialize surfactants, antimicrobials, and polyurethane polyols from Elevan's biobased esters. Solar firm 1366 Technologies has raised $20 million in a Series B funding round. Finance remains an obstacle for biomaterial start-ups, Rivertop Renewables CEO James Stoppert told CW's Alex Scott last week in Edinburgh. In another video interview in Edinburgh, Ian Hudson of DuPont EMEA, tells CW that European biotech firms are well-positioned to compete around the world...
This information is only available to Chemical Week subscribers.
Forgot your user ID or password?
Not an IHS Chemical Week member yet?
Here's why you should be:
100% Satisfaction Guarantee